Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Journal of Acquired Immune Deficiency Syndromes (1999)|September 8, 2009
Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapyKristen M Marks, Robin M A Clarke, James B Bussel, et al.
The Journal of Infectious Diseases|December 17, 2014
Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus-Infected Patients Treated With Telaprevir, Pegylated Interferon, and RibavirinMarija Zeremski, Rositsa B Dimova, Samantha Benjamin, et al.
Addictive Behaviors Reports|March 19, 2026
Improvements in substance use and social determinants of health associated with hepatitis C treatment initiation and sustained virologic response in opioid treatment programsAndrew H Talal, Raktim Mukhopadhyay, Valentina Veronesi, et al.
Seminars in Liver Disease|August 23, 2003
Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2bKimberly A Powers, Narendra M Dixit, Ruy M Ribeiro, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 28, 2024
Methadone metabolism and cytochrome P450 polymorphisms: a systematic review and meta-analysisSeenae Eum, Nicholas P Vernacchia, Nia Doughty, et al.
The Journal of Infectious Diseases|August 4, 2016
Fibrosis Progression in Patients With Chronic Hepatitis C Virus InfectionMarija Zeremski, Rositsa B Dimova, Jaroslaw Pillardy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2012
Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysisRositsa B Dimova, Marija Zeremski, Ira M Jacobson, et al.
Journal of Viral Hepatitis|October 1, 2024
United States Provider Experiences With Telemedicine for Hepatitis C Treatment: A Nationwide SurveyPruthvi Patel, Martin T Wells, Elaine Wethington, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
United States Provider Experiences with Telemedicine for Hepatitis C Treatment: A Nationwide SurveyPruthvi Patel, Martin T Wells, Elaine Wethington, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2013
IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patientsMarija Zeremski, Rositsa B Dimova, Jessy Makeyeva, et al.
Pageof 11